| Dr Anthony Paden, DDS | |
|
223 S Alaska St, Palmer, AK 99645-6335 | |
| (907) 745-6818 | |
| (907) 745-6820 |
| Full Name | Dr Anthony Paden |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 223 S Alaska St, Palmer, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396878062 | NPI | - | NPPES |
| DD5680 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 568 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anthony Paden, DDS Po Box 1969, Palmer, AK 99645-1969 Ph: (907) 745-6818 | Dr Anthony Paden, DDS 223 S Alaska St, Palmer, AK 99645-6335 Ph: (907) 745-6818 |
News Archive
The proportion of working-age Americans who have medical bill problems or who are paying off medical debt climbed from 34 percent to 41 percent between 2005 and 2007, bringing the total to 72 million, according to recent survey findings from The Commonwealth Fund. In addition, 7 million adults age 65 and over also had problems paying medical bills, for a total of 79 million adults with medical bill problems or medical debt.
Using electrodes to stimulate areas deep within the brain may have therapeutic potential for patients with obsessive compulsive disorder that is refractory to treatment, according to a report in the October issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
The U.S. Food and Drug Administration (FDA) yesterday in a press release informed about the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) who have previously failed with one or more treatment. This is the first drug that the FDA has given its approval to in this disease condition.
Selecta Biosciences, Inc., a biopharmaceutical company developing a new class of synthetic vaccines and immunotherapies, today announced that it has initiated a Phase 1 clinical trial to assess the safety, tolerability and pharmacodynamic profile of SEL-068, a nicotine vaccine candidate for smoking cessation and relapse prevention.
› Verified 7 days ago
Dr. Douglas Yale Bowen, DMD, MPH Dentist Medicare: Not Enrolled in Medicare Practice Location: 809 S. Chugach St., Ste. #2, Palmer, AK 99645 Phone: 907-745-5337 Fax: 907-745-5338 | |
Monte L Burtch, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 557 S Alaska St, Palmer, AK 99645 Phone: 907-745-3600 Fax: 907-745-3612 | |
Dr. Hunter Maxwell Paul, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 125 W Evergreen Ave Ste 204, Palmer, AK 99645 Phone: 907-531-3477 | |
Jody R Sessom, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 561 S Denali St, Suite B, Palmer, AK 99645 Phone: 907-745-8122 | |
Dr. Brian David Hutchings, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 223 S Alaska St, Palmer, AK 99645 Phone: 907-745-6818 | |
Mary Coyne, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 11951 E Palmer Wasilla Hwy, Palmer, AK 99645 Phone: 907-745-6288 |